Record Status This is a bibliographic record of a published health technology assessment. No evaluation of the quality of this assessment has been made for the HTA database. Citation HAYES, Inc.. Comparative effectiveness of fiberoptic phototherapy for hyperbilirubinemia in preterm infants. Lansdale: HAYES, Inc.. Directory Publication. 2016 Authors' conclusions Purpose of Technology: Phototherapy is used to treat jaundice in newborns, and to prevent severe hyperbilirubinemia, and its complications. The lights in phototherapy units emit photons that alter the structure of the bilirubin molecule, which can then be excreted in bile or urine. Fiberoptic phototherapy (FPT) systems are light-emitting pads or blankets that are placed under or wrapped around an infant as an adjunct or alternative to standard phototherapy (SPT) delivered by overhead lights.
Relevant Questions: How does FPT compare with SPT for the treatment of hyperbilirubinemia in preterm infants? Is FPT an effective adjunct to SPT for the treatment of hyperbilirubinemia in preterm infants? Is FPT safe in preterm infants? Have definitive patient selection criteria been established for the use of FPT? Indexing Status Subject indexing assigned by CRD MeSH Humans; Hyperbilirubinemia; Infant, Newborn; Infant, Premature; Jaundice; Phototherapy Language Published English Country of organisation United States English summary An English language summary is available. Address for correspondence HAYES, Inc., 157 S. Broad Street, Suite 200, Lansdale, PA 19446, USA. Tel: 215 855 0615; Fax: 215 855 5218 Email: hayesinfo@hayesinc.com AccessionNumber 32016000768 Date abstract record published 14/06/2016 |